Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study.
Carretero-Gómez J, Pérez-Martínez P, Seguí-Ripoll JM, Carrasco-Sánchez FJ, Lois Martínez N, Fernández Pérez E, Pérez Hernández O, García Ordoñez MÁ, Martín González C, Vigueras-Pérez JF, Puchades F, Blasco Avaria MC, Pérez Soto MI, Ena J, Arévalo-Lorido JC, On Behalf Of Diabetes Obesity And Nutrition Working Group Of Spanish Society Of Internal Medicine. Carretero-Gómez J, et al. Among authors: ena j. J Clin Med. 2022 Aug 9;11(16):4644. doi: 10.3390/jcm11164644. J Clin Med. 2022. PMID: 36012889 Free PMC article.
Derivation and validation model for hospital hypoglycemia.
Ena J, Gaviria AZ, Romero-Sánchez M, Carretero-Gómez J, Carrasco-Sánchez FJ, Segura-Heras JV, Porto-Perez AB, Vázquez-Rodriguez P, González-Becerra C, Gómez-Huelgas R; Diabetes and Obesity Working Group of the Spanish Society of Internal Medicine. Ena J, et al. Eur J Intern Med. 2018 Jan;47:43-48. doi: 10.1016/j.ejim.2017.08.024. Epub 2017 Sep 4. Eur J Intern Med. 2018. PMID: 28882417
Combination Therapy With Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients With Type 2 Diabetes: A Real-World Evidence Study.
Carretero Gómez J, Arévalo Lorido JC, Gómez Huelgas R, García de Lucas D, Mateos Polo L, Varela Aguilar JM, Seguí Ripoll JM, Ena J; Diabetes, Obesity, and Nutrition Spanish Working Group. Carretero Gómez J, et al. Among authors: ena j. Can J Diabetes. 2019 Apr;43(3):186-192. doi: 10.1016/j.jcjd.2018.09.001. Epub 2018 Sep 8. Can J Diabetes. 2019. PMID: 30415909
Early biomarkers of diabetic kidney disease. A focus on albuminuria and a new combination of antidiabetic agents.
Carretero Gómez J, Ena J, Seguí Ripoll JM, Carrasco-Sanchez FJ, Gómez Huelgas R, Mateos Polo L, Varela Aguilar JM, Suárez Tembra JM, Arévalo-Lorido JC; Diabetes, Obesity and Nutrition Spanish Working Group. Carretero Gómez J, et al. Among authors: ena j. Int J Clin Pract. 2020 Oct;74(10):e13586. doi: 10.1111/ijcp.13586. Epub 2020 Jul 14. Int J Clin Pract. 2020. PMID: 32533906
Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial.
Perez A, Carrasco-Sánchez FJ, González C, Seguí-Ripoll JM, Trescolí C, Ena J, Borrell M, Gomez Huelgas R. Perez A, et al. Among authors: ena j. BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001518. doi: 10.1136/bmjdrc-2020-001518. BMJ Open Diabetes Res Care. 2020. PMID: 32928792 Free PMC article. Clinical Trial.
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
Pérez-Belmonte LM, Torres-Peña JD, López-Carmona MD, Ayala-Gutiérrez MM, Fuentes-Jiménez F, Jorge Huerta L, Muñoz JA, Rubio-Rivas M, Madrazo M, Garcia MG, Montes BV, Sola JF, Ena J, Ferrer RG, Pérez CM, Ripper CJ, Lecumberri JJN, Acedo IEA, Canteli SP, Cosío SF, Martínez FA, Rodríguez BC, Pérez-Martínez P, Ramos-Rincón JM, Gómez-Huelgas R; SEMI-COVID-19 Network. Pérez-Belmonte LM, et al. Among authors: ena j. BMC Med. 2020 Nov 16;18(1):359. doi: 10.1186/s12916-020-01832-2. BMC Med. 2020. PMID: 33190637 Free PMC article.
Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry.
Torres-Peña JD, Pérez-Belmonte LM, Fuentes-Jiménez F, López Carmona MD, Pérez-Martinez P, López-Miranda J, Carrasco Sánchez FJ, Vargas Núñez JA, Del Corral Beamonte E, Magallanes Gamboa JO, González García A, González Moraleja J, Cortés Troncoso A, Taboada Martínez ML, Del Fidalgo Montero MDP, Seguí Ripol JM, Gil Sánchez R, Alegre González D, Boixeda R, Cortés Rodríguez B, Ena J, García García GM, Ventura Esteve A, Ramos Rincón JM, Gómez-Huelgas R; SEMI-COVID-19 Network. Torres-Peña JD, et al. Among authors: ena j. Drugs. 2021 Apr;81(6):685-695. doi: 10.1007/s40265-021-01498-x. Epub 2021 Mar 29. Drugs. 2021. PMID: 33782908 Free PMC article.
Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity.
Carretero-Gómez J, Carrasco-Sánchez FJ, Fernández-Rodríguez JM, Casado-Escribano P, Miramontes-González JP, Seguí-Ripoll JM, Ena J, Arévalo-Lorido JC; Diabetes, Obesity, and Nutrition Working Group of the Spanish Society of Internal Medicine (SEMI). Carretero-Gómez J, et al. Among authors: ena j. Rev Clin Esp (Barc). 2023 Mar;223(3):134-143. doi: 10.1016/j.rceng.2022.12.001. Epub 2022 Dec 19. Rev Clin Esp (Barc). 2023. PMID: 36549643
153 results